Lv7
4910 积分 2021-09-06 加入
A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma
13小时前
已完结
Urothelial Carcinoma: Update on Staging and Reporting, and Pathologic Changes Following Neoadjuvant Chemotherapies
1个月前
已完结
The dilemma of neoadjuvant and adjuvant therapy in urothelial carcinoma: will immunotherapy solve the problem?
1个月前
已完结
Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods
1个月前
已完结
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 Update
1个月前
已完结
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update
1个月前
已完结
Advancements in immunotherapy for gastric cancer: Unveiling the potential of immune checkpoint inhibitors and emerging strategies
1个月前
已完结
Clinical aspects of spatially fractionated radiation therapy treatments
1个月前
已完结
Spatially Fractionated Radiotherapy in the Era of Immunotherapy
1个月前
已完结
A review of the novel tissue factor antibody–drug conjugate: Tisotumab vedotin
1个月前
已完结
皖公网安备34019202002308
